REG - GlaxoSmithKline PLC - Director/PDMR Shareholding

GSKAnnouncement

09/06/2020 14:20

RNS Number : 4357P
  
GlaxoSmithKline PLC
  
09 June 2020
  
 

GlaxoSmithKline plc (the 'Company')
 
Transaction notification
 




1.


Details of PDMR/person closely associated with them ('PCA')




a)


Name


Ms S Jackson




b)


Position/status


SVP, Global Communications & CEO Office




c)


Initial notification/
amendment


Initial notification




2. 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name 


GlaxoSmithKline plc




b)


LEI


5493000HZTVUYLO1D793




3.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted




a)


Description of the financial  instrument


Ordinary shares of 25 pence each ('Ordinary Shares')
 
ISIN: GB0009252882   




b)


Nature of the transaction


The sale of 1,209 Ordinary Shares to facilitate a transfer into an ISA. 




c)


Price(s) and volume(s)






Price(s)


Volume(s)




£16.5557


1,209




 




d)


Aggregated information
 
Aggregated volume Price


N/A (single transaction)
 
 
 
 
 
 




e)


Date of the transaction


2020-06-04




f)


Place of the transaction
 


London Stock Exchange (XLON)




 
 
 
 




1.


Details of PDMR/person closely associated with them ('PCA')




a)


Name


Ms S Jackson




b)


Position/status


SVP, Global Communications & CEO Office




c)


Initial notification/
amendment


Initial notification




2. 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name 


GlaxoSmithKline plc




b)


LEI


5493000HZTVUYLO1D793




3.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted




a)


Description of the financial  instrument


Ordinary shares of 25 pence each ('Ordinary Shares')
 
ISIN: GB0009252882   




b)


Nature of the transaction


The purchase of 1,200 Ordinary Shares into an ISA.




c)


Price(s) and volume(s)






Price(s)


Volume(s)




£16.5700


1,200








d)


Aggregated information
 
Aggregated volume Price


N/A (single transaction)
 
 
 
 
 
 




e)


Date of the transaction


2020-06-04




f)


Place of the transaction
 


London Stock Exchange (XLON)




 
 
 




1.


Details of PDMR/person closely associated with them ('PCA')




a)


Name


Mr D Jackson




b)


Position/status


PCA of Ms S Jackson (SVP, Global Communications & CEO Office)




c)


Initial notification/
amendment


Initial notification




2. 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name 


GlaxoSmithKline plc




b)


LEI


5493000HZTVUYLO1D793




3.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted




a)


Description of the financial  instrument


Ordinary shares of 25 pence each ('Ordinary Shares')
 
ISIN: GB0009252882  




b)


Nature of the transaction


The sale of 1,209 Ordinary Shares to facilitate a transfer into an ISA.




c)


Price(s) and volume(s)






Price(s)


Volume(s)




£16.5584


1,209




 




d)


Aggregated information
 
Aggregated volume Price


N/A (single transaction)
 
 
 
 
 




e)


Date of the transaction


2020-06-04




f)


Place of the transaction
 


London Stock Exchange (XLON)




 
 
 
 




1.


Details of PDMR/person closely associated with them ('PCA')




a)


Name


Mr D Jackson




b)


Position/status


PCA of Ms S Jackson (SVP, Global Communications & CEO Office)




c)


Initial notification/
amendment


Initial notification




2. 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name 


GlaxoSmithKline plc




b)


LEI


5493000HZTVUYLO1D793




3.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted




a)


Description of the financial instrument


Ordinary shares of 25 pence each ('Ordinary Shares')
 
ISIN: GB0009252882   




b)


Nature of the transaction


The purchase of 1,201 Ordinary Shares into an ISA.




c)


Price(s) and volume(s)






Price(s)


Volume(s)




£16.5460


1,201




 




d)


Aggregated information
 
Aggregated volume Price


N/A (single transaction)
 
 
 
 
 
 




e)


Date of the transaction


2020-06-04




f)


Place of the transaction
 


London Stock Exchange (XLON)




 
 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
DSHXKLFBBQLFBBX